About Asher Bio
Asher Bio develops cis-targeted immunotherapies that selectively activate specific immune cell types. These immunotherapies are designed to treat cancer and infectious diseases. The company aims to provide new medicines for patients.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B+
Global Headquarters
San Francisco, United States
Year Founded
2019
Team Size
3 employees
Tracked Since
Sep 28, 2026
Web & Domain Identity
Official Website
asherbio.com
Domain Registered Date
Jan 28, 2019
Social & Network Presence
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $55,000,000 · Series-B+
fundraisingfox.com
- Capital Raise
Raised $108,000,000 · Series-B+
fundraisingfox.com
- Capital Raise
Raised $55,000,000 · Series-A
- Milestone
X account created (@AsherBio)
189 followers
- Milestone
Website domain registered
asherbio.com
- Milestone
Company founded
San Francisco, United States
Investors & Backers
AstraZeneca
Boxer Capital
Bristol-Myers Squibb
Emles Venture Partners
Invus
Janus Henderson Investors
Logos Capital
Marshall Wace
MBC BioLabs
Mission BioCapital
RA Capital Management
Third Rock Ventures
Wellington Management
Y Combinator
Funding History
Series-B+
· Apr 16, 2024
$55,000,000 fundraisingfox.com
Series-B+
· Sep 1, 2021
$108,000,000 fundraisingfox.com
Series-A
· Mar 23, 2021
$55,000,000 Source
Venture Round
· Undisclosed
Undisclosed Source
Founders & Leadership
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026